Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ELUT

Elutia (ELUT)

Elutia Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELUT
DateTimeSourceHeadlineSymbolCompany
06/10/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
06/10/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
06/10/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
06/07/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
05/13/20245:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
05/13/20248:00AMGlobeNewswire Inc.Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024NASDAQ:ELUTElutia Inc
05/09/20245:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
05/09/20244:05PMGlobeNewswire Inc.Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA ClearanceNASDAQ:ELUTElutia Inc
05/02/20244:05PMGlobeNewswire Inc.Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ELUTElutia Inc
04/24/20244:05PMGlobeNewswire Inc.Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1NASDAQ:ELUTElutia Inc
03/11/20249:15AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ELUTElutia Inc
03/07/20244:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
03/07/20244:05PMGlobeNewswire Inc.Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024NASDAQ:ELUTElutia Inc
02/22/20244:05PMGlobeNewswire Inc.Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024NASDAQ:ELUTElutia Inc
02/14/20244:40PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELUTElutia Inc
02/02/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
01/25/20244:56PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ELUTElutia Inc
01/12/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
01/10/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
01/10/20244:05PMGlobeNewswire Inc.Elutia Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ELUTElutia Inc
01/09/20244:17PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ELUTElutia Inc
01/08/20244:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
12/27/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
12/18/20238:00AMGlobeNewswire Inc.Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA ClearanceNASDAQ:ELUTElutia Inc
12/08/20234:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
12/05/20234:54PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELUTElutia Inc
12/05/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ELUTElutia Inc
11/20/20234:53PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ELUTElutia Inc
11/20/20234:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
11/15/20235:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
 Showing the most relevant articles for your search:NASDAQ:ELUT